BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 27063079)

  • 1. Plasmodium falciparum malaria: Convergent evolutionary trajectories towards delayed clearance following artemisinin treatment.
    Wilairat P; Kümpornsin K; Chookajorn T
    Med Hypotheses; 2016 May; 90():19-22. PubMed ID: 27063079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local emergence in Amazonia of
    Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L
    Elife; 2020 May; 9():. PubMed ID: 32394893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spread of artemisinin resistance in Plasmodium falciparum malaria.
    Ashley EA; Dhorda M; Fairhurst RM; Amaratunga C; Lim P; Suon S; Sreng S; Anderson JM; Mao S; Sam B; Sopha C; Chuor CM; Nguon C; Sovannaroth S; Pukrittayakamee S; Jittamala P; Chotivanich K; Chutasmit K; Suchatsoonthorn C; Runcharoen R; Hien TT; Thuy-Nhien NT; Thanh NV; Phu NH; Htut Y; Han KT; Aye KH; Mokuolu OA; Olaosebikan RR; Folaranmi OO; Mayxay M; Khanthavong M; Hongvanthong B; Newton PN; Onyamboko MA; Fanello CI; Tshefu AK; Mishra N; Valecha N; Phyo AP; Nosten F; Yi P; Tripura R; Borrmann S; Bashraheil M; Peshu J; Faiz MA; Ghose A; Hossain MA; Samad R; Rahman MR; Hasan MM; Islam A; Miotto O; Amato R; MacInnis B; Stalker J; Kwiatkowski DP; Bozdech Z; Jeeyapant A; Cheah PY; Sakulthaew T; Chalk J; Intharabut B; Silamut K; Lee SJ; Vihokhern B; Kunasol C; Imwong M; Tarning J; Taylor WJ; Yeung S; Woodrow CJ; Flegg JA; Das D; Smith J; Venkatesan M; Plowe CV; Stepniewska K; Guerin PJ; Dondorp AM; Day NP; White NJ;
    N Engl J Med; 2014 Jul; 371(5):411-23. PubMed ID: 25075834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach.
    White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM
    PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria.
    Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ;
    J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fighting drug-resistant Plasmodium falciparum: the challenge of artemisinin resistance.
    Wongsrichanalai C; Sibley CH
    Clin Microbiol Infect; 2013 Oct; 19(10):908-16. PubMed ID: 24033691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Plasmodium falciparum Kelch 13 Protein Mutations in P. falciparum Populations from Northeastern Myanmar in Mediating Artemisinin Resistance.
    Siddiqui FA; Boonhok R; Cabrera M; Mbenda HGN; Wang M; Min H; Liang X; Qin J; Zhu X; Miao J; Cao Y; Cui L
    mBio; 2020 Feb; 11(1):. PubMed ID: 32098812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global distribution of polymorphisms associated with delayed Plasmodium falciparum parasite clearance following artemisinin treatment: genotyping of archive blood samples.
    Murai K; Culleton R; Hisaoka T; Endo H; Mita T
    Parasitol Int; 2015 Jun; 64(3):267-73. PubMed ID: 25449286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How genomics is contributing to the fight against artemisinin-resistant malaria parasites.
    Cravo P; Napolitano H; Culleton R
    Acta Trop; 2015 Aug; 148():1-7. PubMed ID: 25910626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artemisinin-Resistant Plasmodium falciparum K13 Mutant Alleles, Thailand-Myanmar Border.
    Boullé M; Witkowski B; Duru V; Sriprawat K; Nair SK; McDew-White M; Anderson TJ; Phyo AP; Menard D; Nosten F
    Emerg Infect Dis; 2016 Aug; 22(8):1503-5. PubMed ID: 27433806
    [No Abstract]   [Full Text] [Related]  

  • 11. Geographic expansion of artemisinin resistance.
    Müller O; Lu GY; von Seidlein L
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30995310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artemisinin Action and Resistance in Plasmodium falciparum.
    Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA
    Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Impact of Sequestration on Artemisinin-Induced Parasite Clearance in Plasmodium falciparum Malaria in Africa.
    Fukuda N; Balikagala B; Ueno T; Anywar DA; Kimura E; Palacpac NMQ; Odongo-Aginya EI; Ogwang M; Horii T; Miida T; Mita T
    Clin Infect Dis; 2023 May; 76(9):1585-1593. PubMed ID: 36519341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.
    Ariey F; Witkowski B; Amaratunga C; Beghain J; Langlois AC; Khim N; Kim S; Duru V; Bouchier C; Ma L; Lim P; Leang R; Duong S; Sreng S; Suon S; Chuor CM; Bout DM; Ménard S; Rogers WO; Genton B; Fandeur T; Miotto O; Ringwald P; Le Bras J; Berry A; Barale JC; Fairhurst RM; Benoit-Vical F; Mercereau-Puijalon O; Ménard D
    Nature; 2014 Jan; 505(7481):50-5. PubMed ID: 24352242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study.
    Imwong M; Suwannasin K; Kunasol C; Sutawong K; Mayxay M; Rekol H; Smithuis FM; Hlaing TM; Tun KM; van der Pluijm RW; Tripura R; Miotto O; Menard D; Dhorda M; Day NPJ; White NJ; Dondorp AM
    Lancet Infect Dis; 2017 May; 17(5):491-497. PubMed ID: 28161569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural selection of K13 mutants of Plasmodium falciparum in response to artemisinin combination therapies in Thailand.
    Putaporntip C; Kuamsab N; Kosuwin R; Tantiwattanasub W; Vejakama P; Sueblinvong T; Seethamchai S; Jongwutiwes S; Hughes AL
    Clin Microbiol Infect; 2016 Mar; 22(3):285.e1-8. PubMed ID: 26548510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Examining Plasmodium falciparum and P. vivax clearance subsequent to antimalarial drug treatment in the Myanmar-China border area based on quantitative real-time polymerase chain reaction.
    Lo E; Nguyen J; Oo W; Hemming-Schroeder E; Zhou G; Yang Z; Cui L; Yan G
    BMC Infect Dis; 2016 Apr; 16():154. PubMed ID: 27084511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single Mutation in K13 Predominates in Southern China and Is Associated With Delayed Clearance of Plasmodium falciparum Following Artemisinin Treatment.
    Huang F; Takala-Harrison S; Jacob CG; Liu H; Sun X; Yang H; Nyunt MM; Adams M; Zhou S; Xia Z; Ringwald P; Bustos MD; Tang L; Plowe CV
    J Infect Dis; 2015 Nov; 212(10):1629-35. PubMed ID: 25910630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of association between polymorphisms in the K13 gene and the presence of Plasmodium falciparum parasites at day 3 after treatment with artemisinin derivatives in Senegal.
    Madamet M; Kounta MB; Wade KA; Lo G; Diawara S; Fall M; Bercion R; Nakoulima A; Fall KB; Benoit N; Gueye MW; Fall B; Diatta B; Pradines B
    Int J Antimicrob Agents; 2017 Jun; 49(6):754-756. PubMed ID: 28450175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiles of Kelch mutations in Plasmodium falciparum across South Asia and their implications for tracking drug resistance.
    Chhibber-Goel J; Sharma A
    Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():49-58. PubMed ID: 31606696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.